Quadrature Capital’s Utah Medical Products UTMD Stock Holding History

Quadrature Capital’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$206K	Buy	+3,321	New	+$209K	﹤0.01%	1111
2024 Q3	–	Sell	-8,521	Closed	-$574K	–	1411
2024 Q2	$574K	Sell	8,521 -23,789	-74%	-$1.62M	0.01%	618
2024 Q1	$2.29M	Buy	32,310 +20,671	+178%	+$1.55M	0.04%	282
2023 Q4	$985K	Sell	11,639 -1,724	-13%	-$143K	0.02%	446
2023 Q3	$1.16M	Buy	13,363 +7,510	+128%	+$693K	0.02%	385
2023 Q2	$546K	Buy	5,853 +1,805	+45%	+$170K	0.01%	562
2023 Q1	$384K	Buy	+4,048	New	+$372K	0.01%	617
2022 Q2	–	Sell	-6,914	Closed	-$619K	–	980
2022 Q1	$619K	Buy	6,914 +426	+7%	+$39.2K	0.02%	358
2021 Q4	$652K	Buy	+6,488	New	+$662K	0.03%	316

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrature Capital's UTMD Position: Q1 2026 in Review

Quadrature Capital opened a new position in Utah Medical Products (UTMD) in Q1 2026: 3,321 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #1111 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in UTMD as recently as Q2 2024.

Quadrature Capital first reported a position in UTMD in Q4 2021 and has held it in 9 quarters since. The position peaked at $2.29M in Q1 2024. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

Quadrature Capital held 3,321 shares of Utah Medical Products worth $206K as of Q1 2026.
Utah Medical Products was a new Quadrature Capital position in Q1 2026.
Utah Medical Products made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1111 holding.
Quadrature Capital first reported a position in Utah Medical Products in Q4 2021 and has held it in 9 quarters since.
Quadrature Capital's Utah Medical Products position peaked at $2.29M in Q1 2024.
119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.